| 1 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66: 115-132.
|
| 2 |
王洪武，金发光. 晚期非小细胞肺癌多域整合治疗策略[J/CD]. 中华肺部疾病杂志(电子版), 2022, 15(4): 457-461.
|
| 3 |
Liu Jingjing, Li Shuang, Zhang Shuang, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab[J]. J Clin Lab Anal, 2019, 8: e22964.
|
| 4 |
Peng F, Hu D, Lin X, et al. The monocyte to red blood cell count ratio is a strong predictor of postoperative survival in colorectal cancer patients: the Fujian prospective investigation of cancer (FIESTA)study[J]. J Cancer, 2017, 8(6): 967-975.
|
| 5 |
Zou ZY, Liu HL, Ning N, et al. Clinical significance of preoperative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer[J]. Oncol Lett, 2016, 11(3): 2241-2248.
|
| 6 |
Guo W, Cai S, Zhang F, et al. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer[J]. Thoracic Cancer, 2019, 10(4): 761-768.
|
| 7 |
Yilmaz U, Ozdemir O, Batum O, et al. The prognostic role of neu-trophil-lymphocyte ratio and platelet-lymphocyte ratio in patientswith stage Ⅲ non-small cell lung cancer treated with concurrent chemoradiotherapy[J]. Indian J Cancer, 2018, 55(3): 276-281.
|
| 8 |
李然天，孙紫千，王红兵. 纤维蛋白原与前白蛋白比值对中晚期非小细胞肺癌预后作用的研究[J]. 临床肿瘤学杂志，2019, 24(3): 237-241.
|
| 9 |
Kim KH, PaJk TY, Lee JY, et al. Pmgnostic significance of initia platelet counts and fibrinogen level jn advanced non-small cell lung cancer[J]. J Korean Med sci, 2014, 29(4): 507-511.
|
| 10 |
Zhu H, Cao X. NLR members in inflammation-associated carcino-genesis[J]. Cell Mol Immunol, 2017, 14(5): 403-405.
|
| 11 |
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6): 883-899.
|
| 12 |
Chen Yongqiang, Wang Weidong, Zhang Xuewen, et al. Prognostic signifcance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-tomonocyte ratio in patients undergoing surgery with stage iB non-small-cell lung cancer[J]. Cancer Manag Res, 2018, 10: 5411-5422.
|
| 13 |
Majeti BK, Lee JH, Simmons BH, et al. VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma[J]. BMC Cancer, 2013, 13: 213 - 216.
|
| 14 |
江冠铭，刘克军，谭钦全，等. 血小板与淋巴细胞比值在表皮生长因子受体突变型非小细胞肺癌靶向治疗疗效与预后评价中的价值[J]. 实用医学杂志，2019, 35(4): 533-536.
|
| 15 |
Capone M, Giannarelli D, Mallardo D, et al. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab[J]．J ImmunoTherapy Cancer, 2018, 6(1): 74.
|
| 16 |
Ogata T, Satake H, Ogata M, et al. Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study[J]. Oncotarget, 2018, 9(77): 34520-34527.
|
| 17 |
Erdem S, Amasyali AS, Aytac O, et al. Increased preoperative levels of plasma fibrinogea and D dimer in patients with renal cell carcinoma is associated with poor survival and adversa tumor characteristics[J]. Urol Oncol, 2014, 32(7): 3710-3714.
|
| 18 |
Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation[J]. Blood, 2000, 96: 3772-3778.
|
| 19 |
Son HJ, Park JW, Chang HJJ, et al. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with non-metastatic colon cancer[J]. Ann Surg Oncol, 2013, 20(9): 2908-2913.
|
| 20 |
Tas F, Kilic L, Bilgin E, et al. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2013, 44(3): 285-292.
|
| 21 |
Li C, Wu J, Jiang L, et al. The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study[J]. Cancer Immunol Immunother, 2023, 72(3): 783-794.
|
| 22 |
卢兴兵，石 佳，李 勤，等. PLR 、NLR参数联合肿瘤标志物在非小细胞肺癌诊断中的价值[J]. 国际检验医学杂志，2019, 40(10): 1223-1226.
|
| 23 |
Sheng L, Luo M, Sun X, et al. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer[J]. Int J Cancer, 2013, 133: 2720-2725.
|
| 24 |
Wang W, Tong Y, Sun S, et al. Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer[J]. Front Oncol, 2022, 12: 936206.
|
| 25 |
Misiewicz A, Dymicka-Piekarska V. Fashionable, but what is their real clinical usefulness? NLR, LMR, and PLR as a promising indicator in colorectal cancer prognosis: A systematic review[J]. J Inflamm Res, 2023, 16: 69-81.
|
| 26 |
Muangto T, Maireang K, Poomtavorn Y, et al. Study on preoperative neutrophil/lymphocyte (NLR) and platelet/lymphocyte ratio (PLR) as a predictive factor in endometrial cancer[J]. Asian Pac J Cancer Prev, 2022, 23(10): 3317-3322.
|
| 27 |
剧素贞，徐爱晖. NLR和PLR对小细胞肺癌患者预后的评估[J]. 临床肺科杂志，2018, 23(12): 2251-2252.
|
| 28 |
Mazzella A, Maiolino E, Maisonneuve P, et al. Systemic inflammation and lung cancer: Is it a real paradigm Prognostic value of inflammatory indexes in patients with resected non-small-cell lung cancer[J]. Cancers (Basel), 2023, 15(6): 1854.
|